Evidence map›Paper›PMID 27473817›Full record

ArticleInternational journal of radiation oncology, biology, physics2016

Geographic Disparity in the Use of Hypofractionated Radiation Therapy Among Elderly Women Undergoing Breast Conservation for Invasive Breast Cancer.

Erin F Gillespie, Rayna K Matsuno, Beibei Xu, Daniel P Triplett, Lindsay Hwang, Isabel J Boero, John P Einck, Catheryn Yashar, James D Murphy

Abstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Dissemination and Implementation-A Primer for Accelerating "Time to Translation" in Radiation Oncology.International journal of radiation oncology, biology, physics · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. In Reply to Dimitroyannis.Practical radiation oncology
    Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Erin F GillespieDepartment of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California.
Rayna K MatsunoDepartment of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California.
Beibei XuDepartment of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California.
Daniel P TriplettDepartment of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California.
Lindsay HwangDepartment of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California.
Isabel J BoeroDepartment of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California.
John P EinckDepartment of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California.
Catheryn YasharDepartment of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California.
James D MurphyDepartment of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California. Electronic address: j2murphy@ucsd.edu.
University of California, San Diego · US

Funding

UC San Diego Clinical and Translational Research InstituteKL2TR001444 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2024
$15.4M
UC San Diego Clinical and Translational Research InstituteTL1TR001443 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2019
$3.4M
San Diego Clinical and Translational Research InstituteKL2TR000099 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S · 2012 to 2014
$1.1M
NCATS NIH HHS KL2 TR000099NCATS NIH HHS KL2 TR001444NCATS NIH HHS TL1 TR001443
6 · The paper itself

Abstract

purposeTo evaluate geographic heterogeneity in the delivery of hypofractionated radiation therapy (RT) for breast cancer among Medicare beneficiaries across the United States. METHODS AND MATERIALS: We identified 190,193 patients from the Centers for Medicare and Medicaid Services Chronic Conditions Warehouse. The study included patients aged >65 years diagnosed with invasive breast cancer treated with breast conservation surgery followed by radiation diagnosed between 2000 and 2012. We analyzed data by hospital referral region based on patient residency ZIP code. The proportion of women who received hypofractionated RT within each region was analyzed over the study period. Multivariable logistic regression models identified predictors of hypofractionated RT.

resultsOver the entire study period we found substantial geographic heterogeneity in the use of hypofractionated RT. The proportion of women receiving hypofractionated breast RT in individual hospital referral regions varied from 0% to 61%. We found no correlation between the use of hypofractionated RT and urban/rural setting or general geographic region. The proportion of hypofractionated RT increased in regions with higher density of radiation oncologists, as well as lower total Medicare reimbursements.

conclusionsThis study demonstrates substantial geographic heterogeneity in the use of hypofractionated RT among elderly women with invasive breast cancer treated with lumpectomy in the United States. This heterogeneity persists despite clinical data from multiple randomized trials proving efficacy and safety compared with standard fractionation, and highlights possible inefficiency in health care delivery.

Indexed as

Radiation Dose HypofractionationAgedAged, 80 and overBreast NeoplasmsFemaleGeographyHealthcare DisparitiesHealth Care RationingHumansMastectomy, SegmentalNeoplasm InvasivenessOrgan Sparing TreatmentsPrevalenceRadiotherapy, AdjuvantRetrospective StudiesRisk Factors

Identifiers

PMID27473817
PMCPMC5014714
OpenAlexW2210583157

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.